<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36979">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02117921</url>
  </required_header>
  <id_info>
    <org_study_id>2013P-000315</org_study_id>
    <nct_id>NCT02117921</nct_id>
  </id_info>
  <brief_title>Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain</brief_title>
  <official_title>Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients
      suffering from chronic pain syndromes without organic etiology.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Brief Pain Inventory Questionnaire</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SF-12 Health Survey Scoring Demonstration</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>SF-12 Health Survey Scoring Demonstration and Brief Pain Inventory Score</measure>
    <time_frame>2 weeks, 4 weeks, 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>MBS therapy education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>One-on-one interview and educational sessions.  Reading material for educational series as below</intervention_name>
    <description>A one-on-one interview with the patient and the principal investigator and group educational sessions. Participants will also be provided with the following books during the intervention period:
&quot;Healing Back Pain&quot; by Dr. John Sarno &quot;Unlearn Your Pain&quot; by Dr. Howard Schubiner &quot;The Mindful Way through Anxiety: Break Free from Chronic Worry and Reclaim Your Life&quot; by Susan Orsillo, PhD &amp; Lizabeth Roemer</description>
    <arm_group_label>MBS therapy education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient 18 &gt; years old

          -  Chronic pain without clear organic etiology after full evaluation by primary care
             physician or subspecialist

          -  Pain persistent for a minimum of 3 days a week for the past three months prior to
             enrollment

        Exclusion Criteria:

          -  Patients &lt; 18 years of age

          -  Diagnosed organic disease as cause of pain, such as but not limited to malignancy,
             neurologic disorder (i.e., amyotrophic lateral sclerosis)

          -  Patients with a diagnosis of significant psychiatric co-morbidities such as
             schizophrenia and bi-polar disorder.  Mild to moderate depression and anxiety will
             not be considered as exclusions

          -  Pregnancy

          -  Severe depression or recent suicide attempt
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael W Donnino, MD</last_name>
    <phone>617-754-2341</phone>
    <email>mdonnino@bidmc.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julia L Balkema, BA</last_name>
    <phone>617-754-2881</phone>
    <email>jbalkema@bidmc.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Michael W Donnino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 16, 2014</lastchanged_date>
  <firstreceived_date>April 16, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beth Israel Deaconess Medical Center</investigator_affiliation>
    <investigator_full_name>Michael Donnino</investigator_full_name>
    <investigator_title>Michael W. Donnino, MA</investigator_title>
  </responsible_party>
  <keyword>Mind Body Syndrome</keyword>
  <keyword>MBS</keyword>
  <keyword>Chronic Pain</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
